IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q2 2021 Holdings

Filed 2021-08-16 | 33 holdings | $7.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$4.8M20,581,01661.8%
Rubius Therapeutics IncCOM78116T103$939.9K38,506,52612.0%
Sana Biotechnology Inc(SANA)COM799566104$673.1K34,239,0188.6%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$342.9K14,378,8024.4%
Evelo Biosciences IncCOM299734103$316.4K23,030,0694.0%
Denali Therapeutics Inc(DNLI)COM24823R105$214.2K2,730,2632.7%
Kaleido Biosciences Inc(KLDO)COM483347100$145.6K19,575,7101.9%
Foghorn Therapeutics Inc(FHTX)COM344174107$135.2K12,674,1201.7%
Sigilon Therapeutics IncCOM82657L107$111.3K10,370,3691.4%
Axcella Health IncCOM05454B105$50.3K12,548,4140.6%
Codiak Biosciences Inc(32W)COM192010106$48.3K2,607,3030.6%
Syros Pharmaceuticals IncCOM87184Q107$16.0K2,938,4940.2%